TY  - GEN
AU  - Thibault,Gilles
AU  - Paintaud,Gilles
AU  - Legendre,Christophe
AU  - Merville,Pierre
AU  - Coulon,Maxime
AU  - Chasseuil,Elodie
AU  - Ternant,David
AU  - Rostaing,Lionel
AU  - Durrbach,Antoine
AU  - Di Giambattista,Fabienne
AU  - Büchler,Matthias
AU  - Lebranchu,Yvon
TI  - CD25 blockade in kidney transplant patients randomized to standard-dose or high-dose basiliximab with cyclosporine, or high-dose basiliximab in a calcineurin inhibitor-free regimen
SN  - 1432-2277
PY  - 2016///1213
KW  - Adult
KW  - Aged
KW  - Antibodies, Blocking
KW  - administration & dosage
KW  - Antibodies, Monoclonal
KW  - Basiliximab
KW  - Calcineurin Inhibitors
KW  - therapeutic use
KW  - Cyclosporine
KW  - Female
KW  - Graft Rejection
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Interleukin-2 Receptor alpha Subunit
KW  - immunology
KW  - Kidney Transplantation
KW  - Male
KW  - Middle Aged
KW  - Prospective Studies
KW  - Recombinant Fusion Proteins
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/tri.12688
ER  -